Skip to main content
Clinical Trials/NCT00798993
NCT00798993CompletedPhase 4

The Effect of 25-hydroxyvitamin D Supplementation and a Structured Exercise Program on Exercise Capacity and Quality of Life in Dialysis Patients

Sir Charles Gairdner Hospital1 site in 1 country19 target enrollmentStarted: January 2009Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
19
Locations
1
Primary Endpoint
Exercise capacity - modified shuttle walk test

Study Overview

Brief Summary

This study aims to examine the effect of 25 hydroxyvitamin D supplementation and a structured exercise program on the exercise capacity and quality of life of haemodialysis patients with 25 hydroxyvitamin D insufficiency.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Stable on dialysis for at least 3 months
  • Able to obtain informed consent
  • Medically stable
  • Dialysis adequacy at target for small solute clearance (ie Kt/V>1.2 or Urea reduction ratio>65%)
  • Serum 25-hydroxyvitamin D levels less than 75nmol/L at baseline

Exclusion Criteria

  • Limb Amputation
  • Impaired cognition
  • Impaired vision
  • Haemoglobin concentration < 110g/L
  • Change in Erythropoiesis stimulating agent dose over the last 2 months
  • Unable or unwilling to comply with exercise program

Arms & Interventions

Structured exercise program

Active Comparator

Participants will be randomised at 3 months into either this group or the comparator of usual exercise.

Intervention: Structured Exercise program (Other)

Vitamin D

Experimental

Cholecalciferol 2000U per day will be given to all participants for the duration of the study

Intervention: Cholecalciferol (25-Hydroxyvitamin D) (Drug)

Usual exercise

Placebo Comparator

Participants randomised to this arm, at 3 months, will continue on their usual exercise routine

Intervention: Usual exercise (Other)

Outcomes

Primary Outcomes

Exercise capacity - modified shuttle walk test

Time Frame: Basesline, 3 & 6 months

Secondary Outcomes

  • Quality of life with KDQOL(Baseline, 3 & 6 months)
  • Quadriceps Strength(Baseline, 3 & 6 months)
  • Serum phosphate(baselibe, 3 & 6 months)
  • Feeling thermometer(Baseline, 3 & 6 months)
  • Timed up and go(baseline, 3 & 6 months)
  • Falls(continuous)
  • Pulse wave velocity(baseline, 3 & 6 months)
  • Bioimpedance(Baseline, 3 & 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Neil Boudville

Associate Professor

Sir Charles Gairdner Hospital

Study Sites (1)

Loading locations...

Similar Trials